Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Coca-Cola Consolidated
COKE
$12.5B
| $1.61M | ﹤0.01% |
25,390
+7,560
| +42% | +$468K |
|
3602
Citi Trends
CTRN
$555M
| $1.61M | ﹤0.01% |
91,362
+43,562
| +91% | +$751K |
|
3603
American Superconductor
AMSC
$1.42B
| $1.61M | ﹤0.01% |
257,171
+216,712
| +536% | +$1.06M |
|
3604
PUT
Vera Therapeutics
VERA
$2.3B
| $1.6M | ﹤0.01% |
+100,000
| New | +$903K |
|
3605
Keros Therapeutics
KROS
$199M
| $1.6M | ﹤0.01% |
39,896
+15,523
| +64% | +$680K |
|
3606
CALL
Elastic
ESTC
$6.84B
| $1.6M | ﹤0.01% |
+25,000
| New | +$1.57M |
|
|
DHC
3607
Diversified Healthcare Trust
DHC
$2.15B
| $1.6M | ﹤0.01% |
711,794
-1,290,313
| -64% | -$1.85M |
|
3608
PUT
State Street Communication Services Select Sector SPDR ETF
XLC
$22.3B
| $1.6M | ﹤0.01% |
24,600
+6,400
| +35% | +$390K |
|
3609
iShares MBS ETF
MBB
$38.9B
| $1.6M | ﹤0.01% |
17,160
-3,909
| -19% | -$368K |
|
3610
Global X Silver Miners ETF NEW
SIL
$3.98B
| $1.6M | ﹤0.01% |
61,558
-242,536
| -80% | -$6.98M |
|
3611
Deutsche Bank
DB
$69B
| $1.6M | ﹤0.01% |
151,928
+73,829
| +95% | +$778K |
|
3612
CALL
iShares MSCI South Korea ETF
EWY
$21.9B
| $1.6M | ﹤0.01% |
25,200
+4,500
| +22% | +$282K |
|
3613
CALL
Jacobs Solutions
J
$15.9B
| $1.59M | ﹤0.01% |
16,200
| – | – |
|
|
ARCE
3614
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $1.59M | ﹤0.01% |
131,104
+74,762
| +133% | +$886K |
|
3615
Esquire Financial Holdings
ESQ
$1.12B
| $1.59M | ﹤0.01% |
34,743
-30,901
| -47% | -$1.27M |
|
3616
Adeia
ADEA
$2.94B
| $1.58M | ﹤0.01% |
143,927
-283,088
| -66% | -$2.58M |
|
|
GAP
3617
CALL
The Gap Inc
GAP
$7.23B
| $1.58M | ﹤0.01% |
177,200
-138,500
| -44% | -$1.24M |
|
3618
1stdibs.com
DIBS
$149M
| $1.58M | ﹤0.01% |
423,091
+391,424
| +1,236% | +$1.49M |
|
3619
CALL
Alcoa
AA
$11.9B
| $1.58M | ﹤0.01% |
46,600
+36,500
| +361% | +$1.33M |
|
3620
PUT
MGIC Investment
MTG
$6.16B
| $1.58M | ﹤0.01% |
+100,000
| New | +$1.48M |
|
|
TCOA
3621
DELISTED
Zalatoris Acquisition Corp.
TCOA
| $1.57M | ﹤0.01% |
152,335
| – | – |
|
3622
SkinHealth Systems
SKIN
$88.8M
| $1.57M | ﹤0.01% |
187,948
+60,586
| +48% | +$630K |
|
3623
CALL
Trade Desk
TTD
$8.48B
| $1.57M | ﹤0.01% |
+20,300
| New | +$1.37M |
|
|
VXRT
3624
DELISTED
Vaxart
VXRT
| $1.56M | ﹤0.01% |
2,143,638
+2,067,766
| +2,725% | +$1.92M |
|
|
FUSN
3625
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $1.56M | ﹤0.01% |
334,577
-69,211
| -17% | -$299K |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.